Llwytho...
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
The response to the coronavirus disease 2019 (COVID-19) pandemic has been hampered by lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antiviral therapy. Here we report the use of remdesivir in a patient with COVID-19 and the prototypic genetic antibody deficiency X-...
Wedi'i Gadw mewn:
Cyhoeddwyd yn: | Nat Commun |
---|---|
Prif Awduron: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
Nature Publishing Group UK
2020
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7736571/ https://ncbi.nlm.nih.gov/pubmed/33318491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-19761-2 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|